<DOC>
	<DOCNO>NCT00660699</DOCNO>
	<brief_summary>To assess feasibility administer induction chemotherapy gemcitabine docetaxel follow concurrent radiation continuous infusion 5FU consolidation gemcitabine/docetaxel chemotherapy .</brief_summary>
	<brief_title>A Feasibility Phase II Study Treatment Resected Cholangiocarcinoma , Gallbladder , Pancreatic Ampullary Cancers</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Patients must biopsyproven , resect curative intent cholangiocarcinoma , gallbladder , pancreatic ampullary adenocarcinoma . Patients must 18 year old . Patients must NCI CTC Performance Status 02 . Patients must prior chemotherapy radiation therapy current malignancy . At least 3 week elapse since surgery require general anesthesia . Patients must prior malignancy except basal squamous skin cancer , cervical carcinomainsitu , unless remission &gt; 5years Pregnant patient eligible . Nonpregnant status determine woman childbearing potential . All patient require use effective mean contraception sexually active therapy . Initial Required Laboratory Values : Absolute neutrophil count ≥ 1,500/mm3 , platelet count ≥ 150 , 000/mm3 , hemoglobin ≥ 9 g/dL . Serum creatinine ≤ 2 mg/dL . Serum bilirubin ≤ 3.0 mg/dL ( biliary stent allow ) . Serum transaminases ≤ 5fold institutional upper limit . Patients must coexist severe medical illness , unstable angina , uncontrolled diabetes mellitus , uncontrolled arrhythmia uncontrolled infection . Patients must able sign inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Cholangiocarcinoma</keyword>
	<keyword>Gallbladder</keyword>
	<keyword>Pancreatic</keyword>
	<keyword>Ampullary</keyword>
	<keyword>Cancer</keyword>
</DOC>